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Abstract: Histamine (HA) is an important food contaminant generated during food fermentation or
spoilage. However, an immunoassay for direct (derivatization free) determination of HA has rarely
been reported due to its small size to induce the desired antibodies by its current hapten-protein
conjugates. In this work, despite violating the classical hapten design criteria which recommend
introducing a linear aliphatic (phenyl free) linker into the immunizing hapten, a novel haptens,
HA-245 designed and synthesized with a phenyl-contained linker, exhibited significantly enhanced
immunological properties. Thus, a quality-improved monoclonal antibody (Mab) against HA was
elicited by its hapten-carrier conjugates. Then, as the linear aliphatic linker contained haptens,
Hapten B was used as linker-heterologous coating haptens to eliminate the recognition of linker
antibodies. Indirect competitive ELISA (ic-ELISA) was developed with a 50% inhibition concentration
(IC50) of 0.21 mg/L and a limit of detection (LOD) of 0.06 mg/L in buffer solution. The average
recoveries of HA from spiked food samples for this ic-ELISA ranged from 84.1% and 108.5%, and the
analysis results agreed well with those of referenced LC-MS/MS. This investigation not only realized
derivatization-free immunoassay for HA, but also provided a valuable guidance for hapten design
and development of immunoassay for small molecules.
Keywords: Histamine; Hapten design; monocloanl antibody; derivatization-free immunoassay
1. Introduction
Histamine (HA) is one of several biogenic amines closely associated with allergies and food
poisonings. Fermented foods and deteriorated protein-rich foods are vulnerable to be contaminated
by a high level of HA [1]. To ensure human health, many countries and communities including
European Union (EU), United States Food and Drug Administration (FDA) and China, have
set a permissible limit for HA in fish products in the range of 50 to 1000 mg/L or kg [2,3].
For effective supervision of HA residues in foods, it is indispensable to develop a rapid and reliable
screening method for HA residues. While several immunoassays for HA have been developed,
most of them were based on antibodies showing a high affinity to HA derivatives, such as
succinylated HA [4], p-benzoquinone−histamine conjugate [5,6], chloroethyl-nitrosourea-histamine
conjugate [7], nitrobenzoylated histamine (NPHA) [8], but negligible affinity to free HA.
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Furthermore, two immunoassays which could directly detect HA without sample derivatization
were developed by Hammar et al [9] and Schneider et al [10], respectively. Hammar et al designed a
HA hapten by attaching a linear aliphatic linker on the ring 1-nitrogen of HA, and conjugated it with
dog serum albumin to form the immunogen. However, Hammar et al’s approach seems inappropriate,
because the resulting monoclonal antibody exhibited a 10-fold higher affinity to 1-Methylhistamine,
one of the main metabolites of HA, than to HA. In Schneider’s work, a specific anti-HA polyclonal
antibody was elicited by an immunogen derived from the conjugation of HA with keyhole limpet
hemocyanin via glutaraldehyde (as a linear aliphatic linker). However, the repeatability of Schneider’s
strategy has been very poor since attempts using the same strategy to produce specific anti-HA
antibodies have failed four times in our group. Besides, the authors further designed another two HA
haptens by appending a linear aliphatic linker in primary amine group (Hapten B, Scheme 1A) and
ring 1-nitrogen (Hapten E, Scheme 1A) of HA, respectively. However, the resulting antisera elicited by
their hapten-protein conjugates still showed low titer and negligible binding affinity to HA [8].
In fact, sample derivatization should be avoided for most immunoassays to shorten the assay time
and simplify the test procedure. Therefore, it is still of great significance to develop an antibody which
could directly bind to HA with desirable affinity, thus developing derivatization-free immunoassay.
Previously, the authors developed an ELISA for the indirect detection of HA [8]. In that work,
a phenyl-contained derivative of HA (Hapten D, Scheme 1A) was employed as an immunizing hapten,
and a polyclonal antibody which could recognize that nitrobenzoylated HA (NPHA) not intact HA was
produced. During the development of ELISA for HA, Hapten B and Hapten C (Scheme 1A) were used
as heterologous coating hapten to enhance assay sensitivity. It was found that the anti-NPHA antibody
showed a high titer of 1:16,000 under Hapten C-OVA coating. This suggests that the anti-NPHA
antibody also has a moderate affinity to acylated HA moiety. However, the anti-NPHA antibody
shows no binding ability to Hapten B-OVA conjugate with the observed absorbance being at a blank
level, suggesting the detrimental effect of modification of the amide (in Hapten C, Scheme 1B) to a
secondary amine (in Hapten B, Scheme 1B). These results meant the incorporation of phenyl into
immunizing hapten could significantly improve immunological properties of resultant anti-hapten
immunogen. However, the benzoylation of HA strikingly changed the electronic properties of the
primary amine nitrogen atom of HA, which might lead to the failure in recognizing the HA moiety
in Hapten B by the anti-NPHA antibody. Therefore, it was queried whether maximizing the charge
distribution similarity with intact HA by N-alkylation of HA with a phenyl-contained linker in its
primary amine group (yield a secondary amine group) might elicit antibodies which could recognize
HA with the desired affinity. Furthermore, the strong recognition of anti-NPHA antibody to acylated
HA moiety also encouraged the hypothesis that, under the prerequisite of maximizing electronic
and conformational similarity between hapten and target molecule, introducing a phenyl-contained
linker into the immunizing hapten to improve immunological properties of anti-hapten immunogen,
integrating with a heterologous coating strategy, might be a good choice for improving the immunoassay
for small molecules. Herein, to investigate the effectiveness of the above hypothesis, hapten HA-245,
which is hapten designed to have a phenyl-contained linker, was employed as immunizing haptens
against HA. Meanwhile, Hapten B, a hapten containing a linear aliphatic linker, was used both as the
control immunizing hapten and linker-heterologous coating hapten.
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2.3. Conjugation of Haptens
As with Hapten B, HA-245 also has a secondary amine and a carboxyl group, thus HA-245 was
conjugated to carriers (BSA or OVA) using the same one-step EDC method as that for preparation of
Hapten B-protein conjugates instead of the two-step activated ester method to avoid lactamization.
Briefly, 0.12 mmol of hapten and 67 mg of BSA (or 45 mg of OVA) were added in 10 mL of H2O.
The resultant solution was cooled in an ice bath and the pH was adjusted to 4.5 with HCl (1M).
Then, 320 mg of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) was added
(with stirring) to the above solution in small portions. The pH of this reaction mixture was kept at
4.5~5.0 (with HCl) throughout the addition of EDC and the mixture was then stirred at 4 ◦C over night.
The conjugation mixture was dialyzed against 10 mM PBS (4 × 5 L) at 4 ◦C for 72 h, and diluted to
1.0 mg/mL with PBS and stored at –20 ◦C until used.
2.4. Antibody Production
Animal manipulations were performed in compliance with the Regulation Guideline for
Experimental Animals issued by the Ministry of Science and Technology of China (Ethical identification
code: SYXK(Yue) 2014-0136; Approval date: 16 May 2017; Ethics committee: Guangdong Provincial
Department of Science and Technology).
Three Babl/c female mice aged 7 weeks were independently injected subcutaneously with 0.1 mg
of immunogen (HA-245-BSA) in 0.2 mL of emulsion (a 1:1 mixture of immunogen (1 mg/mL) and
complete Freund’s adjuvant). The booster immunizations were given 3 times using the same dose
of immunogen emulsified in the incomplete Freund’s adjuvant were given at two-week intervals.
One week after the last immunization, the mice were tail-bled and the blood samples could coagulate
at 37 °C for three hours. Then, the antisera (polyclonal antibody) was separated (4000× g, 30 min)
by centrifugation. The obtained antisera were tested for their anti-hapten antibody titer and binding
properties by non-competitive indirect ELISA and ic-ELISA (the detailed procedure is presented in
ELISA Protocol of Supplementary Materials).
The mouse whose antisera showed the best binding ability to HA was chosen as the donor of spleen
cells for cell fusion. The selected mouse received a final intraperitoneal injection with the same amount
of immunogen in PBS. Three days later, the mouse was exsanguinated for cell fusion. Then, the obtained
spleen cells were fused with SP2/0 murine myeloma cells to form hybridomas using PEG 2000 by the
same procedure as described by Kane and Banks [11]. At 8 to 10 days after the cell fusion, when the
hybridoma cells were grown to approximately 30–40% confluent in the well, culture supernatants were
collected and screened using indirect ELISA for the presence of anti-HA antibodies. The hybridomas
showing the desired specificity were sub-cloned for multiple rounds by the limiting dilution method
until a pure and stable antibody-producing clone was obtained. The positive clones were injected into
female Balb/c mice to obtain ascitic fluid for antibody production. The anti-HA Mab was prepared
through ascites production and purified by ammonium sulfate precipitation followed by a protein-G
column. The obtained anti-HA Mab was stored at –20 ◦C until used.
2.5. ELISA Protocol
The ELISA was constructed based on the regular procedure of competitive indirect ELISA
(ic-ELISA) [12]. For further details, see the Supplementary Materials.
2.6. Cross-Reactivity Test
The specificity of the antibody was assessed by testing cross-reactivities (CRs) with some
compounds (cross-reactants) which are structurally or functionally related with target molecule using
ic-ELISA. The CR was calculated using the following equation:
CR% = IC50 (Histamine)/IC50 (cross-reactants) ×100 (1)
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3. Results
3.1. Characterization of Hapten and Artificial Antigens
Hapten HA-245 designed with a phenyl-contained linker was synthesized by condensation of
HA with 4-formyl-benzoic acid, followed by reduction of schiff base (C-N double bond) to secondary
amine by NaBH4 (Figure 1). Hapten B, a HA hapten having a linear aliphatic linker, had been prepared
in our previous work [8]. The ESI-MS and NMR test results indicated the success of hapten synthesis
(Figures S1 and S2). It was shown in Figure 2 that the HA moiety was well retained in HA-245,
and the phenyl in the linker had a negligible effect on the electronic distribution of HA since only a
slight alteration (Gasteiger−Huckel charge change from −3.27 to −3.00) on N8 atom was observed,
implying that the introduction of phenyl-contained linker induced negligible interference over the
electronic nature of the target moiety as well. HA-245 was conjugated to BSA and OVA as immunogen
and coating antigen, respectively. The resulting hapten-BSA conjugates were of comparable hapten
density, with the hapten to protein molar ratio in the range of 18.3~23.4, as determined by Habeeb’s
TNBS method [13].
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3.2. Production of Monoclonal Antibody
The efficacy of two immunogens (HA-245-BSA, Hapten B-BSA) were assessed by immunization
of groups of n = 3 Balb/c mice. Each immunogen was administered on weeks 0, 2, 4 and 6 with
bleeds taken one week following the last immunization. The anti-HA antiserum titers and binding
properties were determined by ELISA using Hapten B-OVA and HA-245-OVA as coating antigen,
respectively. As shown in Table 1, the mice antiserum elicited by Hapten B-BSA were of low titer and
no binding ability to HA, with the highest titer of 1:4000 and no inhibition even under high level of
HA (50 mg/L), paralleling results with these previously observed for immunization of New Zealand
white rabbits [8]. Gratifyingly, the antiserum against HA-245 were of remarkable enhanced titer with
titer of 1:16,000~1:32,000 and 1:128,000~1:256,000 under Hapten B-OVA coating (heterologous coating)
and HA-245-OVA coating (homologous coating), respectively. Meanwhile, their binding capability
with free HA was observed. As shown in Table 1, anti-HA-245#2 exhibited a moderate inhibition
of 37.5% in the presence of 50 mg/L of HA under homologous coating, but the inhibition increased
significantly to 95.1% when using heterologous coating antigen to eliminate the recognition of the
antibody to the linker. The inhibition curves of anti-HA-245#2 and anti-HaptenB#1 were constructed
using HA-245-OVA and Hapten B-OVA as the coating antigen, respectively. However, no absorbance
was observed for the anti-HaptenB#1@HA-245-OVA antibody@coating antigen combination, thus the
corresponding inhibition curve missed. Figure 3 showed that the anti-HA-245#2@ Hapten B-OVA
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heterologous combination exhibited the highest sensitivity for HA with an IC50 of 0.55 mg/L
which was improved ~100-fold compared to that of the anti-HA-245#2@HA-245-OVA homologous
combination. Therefore, the hapten design strategy proposed above proves to be effective for HA.
Furthermore, the NO.2 mice immunized by immunogen HA-245-BSA was chosen as the donor of
the spleen cells for cell fusion. It was found that five wells among 480 wells were determined to
have positive hybridoma cells which were subcloned five times using the limiting dilution method.
One hybridoma (3E9) secreting Mab showing affinity to the HA was obtained.
Table 1. Characterization of anti-HA serum obtained after the fourth immunization by competitive
and non-competitive ELISA.
Coating Antigen
Antibody Hapten B-OVA HA-245-OVA
Titer b (×103) Inhibition c (%) Titer (×103) Inhibition (%)
anti-Hapten B#1 4 — <1 —
anti-Hapten B#2 2 — <1 —
anti-Hapten B#3 4 — <1 —
anti-HA-245#1 a 16 89.8 128 26.6
anti-HA-245#2 16 95.1 128 37.5
anti-HA-245#3 32 92.3 256 31.8
a anti-HA-245#1 represents the antiserum from NO.1 mice immunized by immunogen derived from hapten HA-245.
b Titer is defined as dilution factor of antiserum with the absorbance at 450 nm being situated at about 1.0 at coating
concentration of 1.0 mg/L. c Percentage inhibition was expressed as follow: inhibition (%) = [1 − (B/B0)] × 100.
B0 was mean absorbance of the wells in the absence of HA; B was mean absorbance of the wells in the presence of
50 mg/L of HA.
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3.3. Development of ic-ELISA for Histamine
The obtained anti-HA Mab was further used to develop an ic-ELISA for HA. To achieve optimal
assay performance, some key parameters including the amount of antibody and coating antigen,
pH and ionic strength of the assay buffer were optimized. Under each condition, ic-ELISA inhibition
curves for HA were developed, and then several index including Amax (the absorbance value of
negative control), IC50 (the HA dose that produce 50% decrease in Amax) and ratio of Amax to IC50
(Amax/IC50) were compared. The highest ratio of Amax to IC50 indicated the optimal condition.
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As shown in Table S1, the optimal coating antigen concentration and antibody dilution was at 500 ng/mL
and 1:16,000, respectively. PBS with series of PO43– strength (5–40 mmol/L), and pH values (5.6–8.5)
were used as a working buffer. As a result, PBS with a PO43– strength of 20 mmol/L and a pH of 6.8
were confirmed to be the optimal working buffer. Under the optimal condition, the standard ic-ELISA
inhibition curve for HA was constructed (Figure 4). The IC50 value and LOD (IC10) were 0.21 mg/L
and 0.06 mg/L, respectively.
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The cross-reactivity (CR) test was carried out by measuring CRs between anti-HA Mab and 
several HA or hapten HA-245 related compounds through ic-ELISA. It was shown in Table 2 that this 
Mab exhibited negligible CRs (< 0.1%) with HA structurally related biogenic amines or L-histidine, 
the precursor of HA. In contrast to the antibody in Hammar’s work [9], anti-HA Mab could not 
recognize 1-Methylhistamine, with the CR below 0.1%. This phenomenon might be due to that the 
linker in hapten HA-245 was attached on the side chain primary amine group of HA. Thus, imidazole 
ring moiety is kept in a position distal from carrier protein, which made it to be the potential 
immunodominant moiety for antibody formation. For 1-Methylhistamine, the methylation in 
imidazole ring 1-nitrogen remarkably changed the geometry and charge distribution of imidazole 
ring, which would make the anti-HA Mab not recognize it. Although the anti-HA Mab showed the 
highest affinity to immunizing hapten (HA-245), with a CR of 39583.3 %, HA-245 is a novel 
compound first synthesized in this work, and does not occur naturally. Thus, it would not interfere 
with the HA analysis by this ic-ELISA. In addition, the anti-HA-245#2 showed negligible CRs with 4-
(aminomethyl)-benzoic acid and benzoic acid which are similar to the linker moiety in hapten HA-
245. These results suggested that ic-ELISA constructed on anti-HA Mab @ Hapten B-OVA 
combination is of good specificity to HA. 
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The cross-reactivity ( R) test as carried out by easuring Rs bet een anti- ab and
several or hapten -245 related co pounds through ic-ELIS . It as sho n in Table 2 that this
ab exhibited negligible s ( 0.1 ) ith structurally related biogenic a ines or L-histidine,
the precursor of HA. In contrast to the antibody in Hammar’s work [9], anti-HA Mab could not recognize
1-Methylhistamine, with the CR below 0.1%. This phenomenon might be due to that the linker in hapten
HA-245 was attached on the side chain primary amine group of HA. Thus, imidazole ring moiety
is kept in a position distal from carrier protein, which made it to be the potential immunodominant
oiety for antibody formation. For 1-Methylhistamine, the methylation in imidazole ring 1-nitrogen
remarkably changed the geo etry and charge distribution of imidazole ring, which would ake the
anti-HA Mab not recognize it. Although the anti-HA Mab showed the highest affinity to immunizing
hapten (HA-245), with a CR of 39,583.3%, HA-245 is a novel compound first synthesized in this work,
and does not occur naturally. Thus, it would not interfere with the HA analysis by this ic-ELISA.
In addition, the anti-HA-245#2 showed negligible CRs with 4-(aminomethyl)-benzoic acid and benzoic
acid which are similar to the linker moiety in hapten HA-245. These results suggested that ic-ELISA
constructed on anti-HA Mab @ Hapten B-OV combination is of good specificity to A.
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Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds.
Compound Structure IC50 (mg/L) CR (%)
HA
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Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds. 
Compound Structure IC50（mg/L） CR（%） 
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1-Methyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benzoic acid  
>5000 <0.1 
Benzoic acid 
 
>5000 <0.1 
The high levels of HA usually contaminate seafood, especially, Scombroid fish such as tuna, 
mackerel, bonito, and saury that are rich in free histidine in their muscle [14,15]. Meanwhile, the HA 
content in fermented foods, such as wine, soy sauce, and yoghurt might also significantly increase 
due to microbial action [16–18]. Therefore, saury, red wine, soy sauce and yoghurt samples were 
chosen as model sample matrices to assess the reliability of the ic-ELISA for real samples analysis. 
Initially, the sample matrix effect should be evaluated and overcome. The spiked samples were 
extracted, diluted 5-fold, 10-fold, 20-fold and 40-fold with PBS (10 mM, pH 7.4), respectively, and 
then analyzed by ic-ELISA. As shown in Figure S3, the interferences from the sample matrix 
gradually bated as the dilution increased; and satisfactory recoveries for HA fortified food samples 
(saury fish: 85.6 %; red wine: 88.3%; soy sauce: 95.2% for spiked; yoghurt 93.1%) were achieved, when 
the fortified saury fish sample extract, fortified red wine sample, fortified soy sauce sample extract 
and fortified yoghurt sample extract were diluted 20-fold, 10-fold, 10-fold and 10-fold, respectively. 
Therefore, a dilution factor of 20-fold for saury samples and 10-fold for red wine, soy sauce and 
yoghurt samples were adopted during sample preparation. As a result, the sample preparation 
procedures were as follow: 2 g of saury fish sample was mixed with 2 mL of distilled water and 
homogenized, and then 2 g of the homogenate was added to 18 mL of PBS (10 mM, pH 7.4), and 
vibrated for 1 min. The mixture was centrifuged at 3000× g for 10 min, after removing the fat layer, 
the supernatant was ready for ic-ELISA analysis. Then, 1 mL of red wine or soy sauce was diluted 
10-fold in PBS (10 mM, pH 7.4) and subjected to the ic-ELISA analysis. Further, 1 g of yoghourt and 
9 mL of PBS (10 mM, pH 7.4) were mixed and vibrated for 1 min. The mixture was centrifuged at 
3000× g for 10 min, the supernatant was ready for ic-ELISA analysis. 
0.21 100
Hapten-HA-245
Biomolecules 2019, 9, x 8 of 12 
Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds. 
Compound Structure IC50（mg/L） CR（%） 
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1-Methyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benzoic acid  
>5000 <0.1 
Benzoic acid 
 
>5000 <0.1 
The high levels of HA usually contaminate seafood, especially, Scombroid fish such as tuna, 
mackerel, bonito, and saury that are rich in free histidine in their muscle [14,15]. Meanwhile, the HA 
content in fermented foods, such as wine, soy sauce, and yoghurt might also significantly increase 
due to microbial action [16–18]. Therefore, saury, red wine, soy sauce and yoghurt samples were 
chosen as model sample matrices to assess the reliability of the ic-ELISA for real samples analysis. 
Initially, the sample matrix effect should be evaluated and overcome. The spiked samples were 
extracted, diluted 5-fold, 10-fold, 20-fold and 40-fold with PBS (10 mM, pH 7.4), respectively, and 
then analyzed by ic-ELISA. As shown in Figure S3, the interferences from the sample matrix 
gradually bated as the dilution increased; and satisfactory recoveries for HA fortified food samples 
(saury fish: 85.6 %; red wine: 88.3%; soy sauce: 95.2% for spiked; yoghurt 93.1%) were achieved, when 
the fortified saury fish sample extract, fortified red wine sample, fortified soy sauce sample extract 
and fortified yoghurt sample extract were diluted 20-fold, 10-fold, 10-fold and 10-fold, respectively. 
Therefore, a dilution factor of 20-fold for saury samples and 10-fold for red wine, soy sauce and 
yoghurt samples were adopted during sample preparation. As a result, the sample preparation 
procedures were as follow: 2 g of saury fish sample was mixed with 2 mL of distilled water and 
homogenized, and then 2 g of the homogenate was added to 18 mL of PBS (10 mM, pH 7.4), and 
vibrated for 1 min. The mixture was centrifuged at 3000× g for 10 min, after removing the fat layer, 
the supernatant was ready for ic-ELISA analysis. Then, 1 mL of red wine or soy sauce was diluted 
10-fold in PBS (10 mM, pH 7.4) and subjected to the ic-ELISA analysis. Further, 1 g of yoghourt and 
9 mL of PBS (10 mM, pH 7.4) were mixed and vibrated for 1 min. The mixture was centrifuged at 
3000× g for 10 min, the supernatant was ready for ic-ELISA analysis. 
0.0012 39,583.3
L-histidine
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Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds. 
Compound Structure IC50（mg/L） CR（%） 
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1-Methyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benzoic acid  
>5000 <0.1 
Benzoic acid 
 
>5000 <0.1 
The high levels of HA usually contaminate seafood, especially, Scombroid fish such as tuna, 
mackerel, bonito, and saury that are rich in free histidine in their muscle [14,15]. Meanwhile, the HA 
content in fermented foods, such as wine, soy sauce, and yoghurt might also significantly increase 
due to microbial action [16–18]. Therefore, saury, red wine, soy sauce and yoghurt samples were 
chosen as model sample matrices to assess the reliability of the ic-ELISA for real samples analysis. 
Initially, the sample matrix effect should be evaluated and overcome. The spiked samples were 
extracted, diluted 5-fold, 10-fold, 20-fold and 40-fold with PBS (10 M, pH 7.4), respectively, and 
then analyzed by ic-ELISA. As shown in Figure S3, the interferences from the sample matrix 
gradually bated as the dilution increased; and satisfactory recoveries for HA fortified food sa ples 
(saury fish: 85.6 %; red wine: 88.3%; soy sauce: 95.2% for spiked; yoghurt 93.1%) were achieved, when 
the fortified saury fish sample extract, fortified red wine sample, fortified soy sauce sample extract 
and fortified yoghurt sample extract were diluted 20-fold, 10-fold, 10-fold and 10-fold, respectively. 
Therefore, a dilution factor of 20-fold for saury samples and 10-fold for red wine, soy sauce and 
yoghurt samples were adopted during sample preparation. As a result, the sample preparation 
procedures were as follow: 2 g of saury fish sample was mixed with 2 mL of distilled water and 
homogenized, and then 2 g of the homogenate was added to 18 mL of PBS (10 mM, pH 7.4), and 
vibrated for 1 min. The mixture was centrifuged at 3000× g for 10 in, after removing the fat layer, 
the supernatant was ready for ic-ELISA analysis. Then, 1 mL of red wine or soy sauce was diluted 
10-fold in PBS (10 mM, pH 7.4) and subjected to the ic-ELISA analysis. Further, 1 g of yoghourt and 
9 mL of PBS (10 mM, pH 7.4) were mixed and vibrated for 1 min. The mixture was centrifuged at 
3000× g for 10 min, the supernatant was ready for ic-ELISA analysis. 
>5000 <0.1
1-Methyl-histamine
Biomolecules 2019, 9, x 8 of 12 
Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds. 
Compound Structure IC50（mg/L） CR（%） 
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1-Methyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benzoic acid  
>5000 <0.1 
Benzoic acid 
 
>5000 <0.1 
The high levels of HA usually contaminate seafood, especially, Scombroid fish such as tuna, 
macker l, bonito, and saury that are rich in free hi tidine in their muscle [14,15]. Meanwhile, the HA
content in fermente  foods, such as wine, soy sauce, and yoghurt might also significantly increase
due to microbial action [16–18]. Therefore, saury, red wine, soy sauce and yoghurt samples wer  
chosen as mode sample matrices to assess the eliability of the ic-ELISA for real samples analysis.
Initially, the sample matrix eff ct should be evaluated and overcome. The spiked samples were
extr cted, diluted 5-fold, 10-fold, 20-fold and 40-fold with PBS (10 M, pH 7.4), respectiv ly, and
then analyzed by ic-ELISA. As shown in Figure S3, t e interferences from the sample matrix
gradually bated as the dilution increased; and satisfactory recoveries for HA for ified food samples 
(s ury fish: 85.6 %; red w ne: 88.3%; soy sauce: 95.2% for spik d; yoghurt 93.1%) were achieved, wh n
the fort fied saury fish sample extract, fortified red wine sample, fortified soy sauce sample extract
and fortified yoghurt sample extract were d luted 20-fold, 10-fold, 10- ol and 10-fold, resp ctively.
Therefore, a dilution f ctor of 20-fold for sa ry samples and 10-fold for re wine, soy sauce and
yoghurt samples were adopted during sample preparatio . As a result, the sample preparation
procedures were as follow: 2 g of saury fish sample w s mixed with 2 mL of distill d water and
homogenized, and then 2 g of the homogenate was added to 18 mL of PBS (10 mM, pH 7.4), 
vibrated for 1 min. The mixture was centrifuged at 3000× g f r 10 in, after removing the fat layer, 
the supernatant was r ady fo  ic-ELISA analysis. Then, 1 mL of red wine or soy sauce was dilut d
10-fold in PBS (10 mM, pH 7.4) and subjected to the ic-ELISA analysis. Further, 1 g of yoghourt an
9 mL of PBS (10 mM, pH 7.4) were mix d and vibrated for 1 min. The mixture was centrif ged at
3000× g for 10 min, the supernatant was ready for ic-ELISA analysis. 
>5000 <0.1
Tryptophan
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>5000 <0.1
Tryptamine
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Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds. 
Compound Structure IC50（mg/L） CR（%） 
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1-Methyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benzoic acid  
>5000 <0.1 
Benzoic acid 
 
>5000 <0.1 
The high levels of HA usually contaminate seafood, especially, Scombroid fish such as tuna, 
macker l, bonito, and saury that are rich in free histidine in their muscle [14,15]. eanwhile, the HA 
content in fermente  foods, such as wine, soy sauce, and yoghurt might also significantly increase 
due to microbial action [16–18]. Therefore, saury, red wine, soy sauce and yoghurt samples wer  
chosen as model sample matrices to assess the reliability of the ic-ELISA for real samples analysis. 
Initially, the sample matrix eff ct should be evaluated and overcome. The spiked samples were 
extr cted, diluted 5-fold, 10-fold, 20-fold and 40-fold with PBS (10 m , pH 7.4), respectiv ly, and 
then analyzed by ic-ELISA. As shown in Figure S3, t e interferences from the sample matrix 
gradually bated as the dilution increased; and satisfactory recoveries for HA fortified food sa ples 
(s ury fish: 85.6 %; red wine: 88.3%; soy sauce: 95.2% for spik d; yoghurt 93.1%) were achieved, wh n 
the fortified saury fish sample extract, fortified red wine sample, fortified soy sauce sample extract 
and fortified yoghurt sample extract were diluted 20-fold, 10-fold, 10-fol  and 10-fold, resp ctively. 
Therefore, a dilution f ctor of 20-fold for sa ry samples and 10-fold for re  wine, soy sauce and 
yoghurt samples were adopted during sample preparatio . As a result, the sample preparation 
procedures were as follow: 2 g of saury fish sample w s mixed with 2 mL of distill d water and 
homogenized, and then 2 g of the homogenate was added to 18 mL of PBS (10 m , pH 7.4),  
vibrated for 1 min. The mixture was centrifuged at 3000× g f r 10 min, after removing the fat layer, 
the supernatant was r ady for ic-ELISA analysis. Then, 1 mL of red wine or soy sauce was dilut d 
10-fold in PBS (10 m , pH 7.4) and subjected to the ic-ELISA analysis. Further, 1 g of yoghourt an  
9 mL of PBS (10 m , pH 7.4) were mix d and vibrated for 1 min. The mixture was centrif ged at 
3000× g for 10 min, the supernatant was ready for ic-ELISA analysis. 
>5000 <0.1
Tyramine
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>5000 <0.1
Phenethylamine
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Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds. 
Compound Structure IC50（mg/L） CR（%） 
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1-Methyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benz ic acid  
>5000 <0.1 
Benzoic acid 
 
>5000 <0.1 
The high levels of HA usually contaminate seafood, especially, Scombroid fish such as tuna, 
mackerel, bonito, and saury that are rich in free histidine in their muscle [14,15]. eanwhile, the HA 
content in fermented foods, such as wine, soy sauce, and yoghurt might also significantly increase 
due to microbial action [16–18]. Therefore, saury, red wine, soy sauce and yoghurt samples were 
chosen as model sample matrices to assess the reliability of the ic-ELISA for real samples analysis. 
Initially, the sample atrix effect should be evaluated and overcome. The spiked samples were 
extracted, diluted 5-fold, 10-fold, 20-fold and 40-fold with PBS (10 , pH 7.4), respectively, and 
then analyzed by ic-ELISA. As shown in Figure S3, the interferences from the sample matrix 
gradually bated as the dilution increased; and satisfactory recoveries for HA fortified food sa ples 
(saury fish: 85.6 %; red wine: 88.3%; soy sauce: 95.2% for spiked; yoghurt 93.1%) were achieved, when 
the fortified saury fish sample extract, fortified red wine sample, fortified soy sauce sample extract 
and fortified yoghurt sample extract were diluted 20-fold, 10-fold, 10-fold and 10-fold, respectively. 
Therefore, a dilution factor of 20-fold for saury samples and 10-fold for red wine, soy sauce and 
yoghurt samples were adopted during sample preparation. As a result, the sample preparation 
procedures were as follow: 2 g of saury fish sample was mixed with 2 mL of distilled water and 
homogenized, and then 2 g of the homogenate was added to 18 mL of PBS (10 m , pH 7.4), and 
vibrated for 1 min. The mixture was centrifuged at 3000× g for 10 in, after removing the fat layer, 
the supernatant was ready for ic-ELISA analysis. Then, 1 mL of red wine or soy sauce was diluted 
10-fold in PBS (10 m , pH 7.4) and subjected to the ic-ELISA analysis. Further, 1 g of yoghourt and 
9 mL of PBS (10 m , pH 7.4) were mixed an  vibrated for 1 min. The mixture was centrifuged at 
3000× g for 10 min, the supernatant was ready for ic-ELISA analysis. 
>5000 <0.1
4-(aminomethyl)-benzoic acid
Biomolecules 2019, 9, x 8 of 12 
Table 2. The cross-reactivity of anti-HA ab with HA and related compounds. 
Compound Structure IC50 mg/L  CR %  
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1- ethyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benz ic acid  
>5000 <0.1 
B i  i  
 
>5000 <0.1 
The high levels of HA usually conta inate seafood, especially, Sco broid fish such as tuna, 
acker l, bonito, and saury that are rich in free hi tidine in their uscle [14,15]. Meanwhile, the HA 
content in fer ente  foods, such as wine, soy sauce, and yoghurt ight also significantly increase 
due to icrobial action [16–18]. Therefore, saury, red wine, soy sauce and yoghurt sa ples wer  
chosen as ode sa ple atrices to assess the eliability of the ic-ELISA for real sa ples analysis. 
Initially, the sa ple matrix eff ct should be evaluated and overco e. The spiked sa ples ere
extr cted, diluted 5-fold, 10-fold, 20-fold and 40-fold with PBS (10 M, pH 7.4), respectiv ly, and 
then analyzed by ic-ELISA. As shown in Figure S3, t e interferences fro  the sa ple atrix 
gradually bated as the dilution increased; and satisfactory recoveries for HA for ified food samples 
(s ury fish: 85.6 %; red wine: 88.3%; soy sauce: 95.2% for spik d; yoghurt 93.1%) wer  achieved, wh n 
the fort fied saury fish sa ple extract, fortified red wine sa ple, fortified soy sauce sa ple extract 
and fortified yoghurt sa ple extract were d luted 20-fold, 10-fold, 10- ol and 10-fold, respectively. 
Therefore, a dilution f ctor of 20-fold for sa ry sa ples and 10-fold for re wine, soy sauce and
yoghurt sa ples were adopted during sa ple preparatio . As a result, the sa ple preparation 
procedures were as follow: 2 g of saury fish sa ple w s ixed with 2 L of distill d water and
ho ogenized, and then 2 g of the ho ogenate was added to 18 L of PBS (10 M, pH 7.4),  
vibrated for 1 in. The ixture was centrifug d at 3000× g f r 10 in, after re oving the fat layer, 
the supernatant was r ady fo  ic-ELISA analysis. Then, 1 L of red wine or soy sauce was dilut d
10-fold in PBS (10 M, pH 7.4) and subjected to the ic-ELISA analysis. Further, 1 g of yoghourt an  
9 L of PBS (10 M, pH 7.4) were ix d and vibrated for 1 in. The ixture was centrif ged at
3000× g for 10 in, the supernatant was ready for ic-ELISA analysis. 
>5000 <0.1
Benzoic acid
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Table 2. The cross-reactivity of anti-HA Mab with HA and related compounds. 
Compound Structure IC50（mg/L） CR（%） 
HA 
 
0.21 100 
Hapten-HA-245 
 
0.0012 39583.3 
L-histidine 
 
>5000 <0.1 
1-Methyl-
histamine  
>5000 <0.1 
Tryptophan 
 
>5000 <0.1 
Tryptamine 
 
>5000 <0.1 
Tyramine 
 
>5000 <0.1 
Phenethylamine 
 
>5000 <0.1 
4-(aminomethyl)-
benzoic acid  
>5000 <0.1 
Benzoic acid 
 
>5000 <0.1 
The high levels of HA usually contaminate seafood, especially, Scombroid fish such as tuna, 
macker l, bonito, and saury that are rich in free hi tidine in their muscle [14,15]. eanwhile, the HA
content in ferm nted foods, such as wine, soy sauce, an  yoghurt might also significantly increase
due to microbial ction [16–18]. Therefore, saury, red wine, soy sauc and yoghurt samples wer
hos  as m de  sample matri es to ass ss the eliability of the ic-ELISA for real samples a alysis.
Initially, the sample atrix eff ct should be eva uated and overcom . The spiked 
extr cted, diluted 5-fold, 10-fold, 20-f ld and 40-fold with PBS (10 , pH 7.4), respectiv ly, and
then analyzed by ic-ELISA. As shown in Figure S3, the interferences from the ample matrix
gradually bated as the ilution increase ; and satisfactory recoveries for HA for ifi d food sa ples
(saury fish: 85.6 %; red w ne: 88.3%; soy sauce: 95.2% for spik d; yoghurt 93.1%) wer  achiev d, when
the fort fied saury fish sample extract, fortified red wine sample, fortified soy sauc  sample extract
and fortified yoghurt sample xtract were diluted 20-fold, 10-fold, 10-fol  and 10-fold, r sp ctively.
Therefore, a dilution f ctor of 20-fold sa ry sampl s nd 10- ld for re wine, oy sauce and
yoghu  samples were adopt d during sampl  preparatio . As a result, the sample preparation
proc dures were as follow: 2 g of saury fi h sample w s mixed with 2 mL of distil d wate
h mogenized, and th n 2 g of the homogenate was added to 18 mL of PBS (10 , pH 7.4),
vibrated for 1 min. The mixture wa  centr fuged at 3000× g for 0 in, after removing the fat layer,
the supernatant was r ady f r ic-ELISA analysis. Then, 1 mL of red wine or soy sauce was dilut
10-fold in PBS (10 m , pH 7.4) and subjected to the ic-ELISA analys s. Further, 1 g of yoghourt an
9 mL of PBS (10 m , pH 7.4) were mix d nd vibrated for 1 min. The mixture w s centrif ged at
3 00× g for 10 min, the supernat t was ready f r ic-ELISA an lysis. 
>5000 <0.1
The high levels of HA usually contaminate se food, specially Scombroid fish such as tuna,
mackerel, bonito, and saury that are rich in fre histidine in the r muscl [14,15]. M anwhile, the HA
content in ferm d f ods, such as wine, soy sauce, and yoghurt might also significantly increa e
due to microbial action [16–18]. Therefore, s u y, r d wine, soy sauc and yoghurt samples were
chosen as m del sample matrices t assess the reliabilit of th c-ELISA for real s mple aly is.
Initially, the sample atrix eff ct should be ev l at d nd overcom . Th spiked samples were
extracted, dilu ed 5-fol , 10-fold, 20-fold an 40-fold with PBS (10 mM, pH 7.4), respectiv ly, nd then
analyzed by ic-ELISA. As shown in Figure S3, the interfer nces rom the sampl matrix gradually bated
as the dilution incre sed; an satisfactory recov ries for HA fortified food sampl s (saury fish: 85.6%;
red wine: 88.3%; soy sauce: 95.2% for spiked; yoghurt 93.1%) were ac ieved, w the ortified s ury
fish sample extract, ortifie red wine sample, for ified soy uce sam le extract and fortified yoghurt
sample extract were diluted 20-fold, 10-fold, 10-fold and 10-fold, espectiv ly. Therefore, a dilution
factor of 20-fold saur samples nd 10-fold for re wine, soy sauce and y ghurt amples were
adopted during sample r paration. As a result, the sa le procedures w r as low:
2 g of saury fis sample wa mix d ith 2 mL of dist lled water nd homogen z d, and then 2 g f
the homogenate wa dd d to 18 mL f PBS (10 M, pH 7.4), an vibrated for 1 min. The mixture
was centrifuged at 3000× g for 10 in, after removing th f t ayer, the supernatant was ready for
ic-ELISA analy is. Then, 1 mL of re wine or soy sauce wa dilute 10-f ld in PBS (10 mM, pH 7.4)
and subjected to he ic-ELISA analysis. F ther, 1 g of yoghourt and 9 mL f PBS (10 mM, pH 7.4) were
mixed and vibrated for 1 min. The mixture as centrifuged at 3000× g for 0 min, t supernatant was
ready for ic-ELISA analysis.
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The recovery tests for the intra-assay and inter-assay were performed by analyzing saury, red wine,
soy sauce and yoghurt samples spiked with four levels of HA (0, 2.0, 5.0 and 10.0 mg/L or kg). As shown
in Table 3, the average recoveries for intra-assay were from 87.5% to 106.8%, with the coefficient of
variation below 15.0%. For the inter-assay, the average recoveries were between 84.1% and 108.5%,
with the CV ranging from 7.9% to 14.0%. These results of intra-assay and inter-assay indicated that
this ic-ELISA has good accuracy and precision.
Table 3. Recoveries of histamine from spiked food samples by ic-ELISA (n = 3).
Sample
Spiked (mg
/kg or mg/L)
Intra-Assay a Inter-Assay b
Measured (mg
/kg or mg/L)
Recovery
(%) CV (%)
Measured (mg
/kg or mg/L)
Recovery
(%) CV (%)
Saury
0 2.31 — 13.0 2.40 — 12.5
2.0 4.05 87.5 15.0 4.32 96.0 14.0
5.0 6.72 88.4 10.4 7.27 97.4 11.1
10.0 11.25 89.5 11.6 10.81 84.1 13.0
Red Wine
0 0.91 — 11.1 1.13 — 10.7
2.0 2.80 95.0 10.7 2.95 92.5 10.3
5.0 6.44 106.8 7.8 6.36 105.2 7.9
10.0 10.58 96.8 10.5 11.22 101.2 11.6
Soy Sauce
0 1.22 — 12.6 1.30 — 11.8
2.0 3.08 93.0 10.5 3.28 99.0 10.5
5.0 6.35 102.6 13.2 6.24 98.8 12.1
10.0 10.1 88.8 12.1 9.82 85.2 13.2
Yoghurt
0 ND c — — ND c — —
2.0 1.92 96.0 10.2 2.16 108.5 12.6
5.0 5.24 104.8 11.4 4.96 99.2 10.8
10.0 9.76 97.6 13.6 10.24 102.4 11.8
a intra-assay variation was determined by three replicates on a single day. b inter-assay variation was determined
by three replicates on three consecutive days. c ND, not detected. Data were below the LOD of the assay in
corresponding sample.
Sixteen blind samples were purchased from local supermarkets, then their HA contents were
analyzed by both this ic-ELISA and LC-MS/MS which was established in our previous work [8],
respectively. As shown in Table S2, the results of the ic-ELISA correlated well with those of LC-MS/MS,
suggesting the good accuracy and reliability of the ic-ELISA for detection of HA in real samples.
4. Discussion
The incorporation of a linker ending with a reactive group when designing hapten was generally
preferred. According to conventional hapten design criteria, a linear aliphatic linker with a length of 2
to 6 carbon atoms was preferable for an optimal hapten, since it caused minimum physico-chemical
and antigenic interference over the hapten. To produce the desired antibodies, much more attention has
been invested on the effect of the hapten linker site on the binding properties (affinity and specificity)
of resultant antibodies, since the linker site would mold the final conformation of the conjugate and
thus settle the specific moieties that could be accessible for binding. For example, Mercader et al.
produced a high-affinity anti-pyraclostrobin antibody by synthesizing a series of anti-pyraclostrobin
haptens with the same aliphatic linkers located at different sites, and found that the lower titers and
affinities of one set of antibodies were most likely due to the conformational effects of the linker on the
immunizing bioconjugate [19]. Wang et al. found that four linker sites on R-(−)-salbutamol modulating
the class specificity of the resultant antibodies against 31 β-Agonists [20]. However, for smaller
molecules like HA, acrylamide, ethyl carbamate and 3-amino-2-oxazolidinone (AOZ) with simpler
structure and limited site for tethering the linker, shifting the linker site exerted negligible effect on the
quality of the resultant antibodies, since almost all of the resulting antibodies against conventionally
designed haptens exhibited low titer and negligible affinity for target molecules (as summarized in
Table S3). These results suggested that these conventionally designed haptens failed to evoke significant
anti-hapten immune response. It is generally agreed that a weak interaction of T cell receptor (TCRs)
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with antigenic molecules bound and presented by the major histocompatibility complex (MHC) may
result in the failure in evoking a significant immune response [21]. Despite introducing a linear aliphatic
linker, these conventionally designed haptens are still of diminutive size and low hydrophobicity
which are adverse factors for T cell receptor binding [22]. In contrast, the remarkably enhanced quality
of antibodies elicited by hapten HA-245 sharing a phenyl-contained linker indicated that the phenyl
contributed significantly to the markedly improved immune response against HA. This could be
attributed to the increased size and hydrophobicity in hapten resulting from the incorporation of
phenyl, thus boosting TCR binding and overcoming the poor immunogenicity of native hapten.
Nonetheless, it should be noted that the incorporation of phenyl-contained linker should induce a
minimum possible alteration in the electronic and conformational properties of the target molecules.
As seen with the anti-NPHA hapten (Hapten D, Scheme 1A) mentioned above, it is a phenyl-contained
derivative synthesized by benzoylation of HA with a phenyl-contained linker in the primary amine of
HA. However, the resulting antibodies could not recognize the intact HA but acylated HA moiety,
which is likely due to the significant change of charge distribution on N8 atom of HA (Gasteiger−Huckel
charge change from −3.27 to −2.84) resulting from the modification of primary amine to amide.
Nevertheless, hapten HA-245 synthesized via N-alkylation of HA with a phenyl-contained linker in its
primary amine group with a slight modification of a charge distribution on N8 atom, elicited antibodies
which could recognize intact HA with desired affinity.
As guided by classical hapten design criteria, phenyl should not be incorporated into linker
because it is easy to elicit linker antibodies and thereby induce linker recognition. Actually, in this work,
all resulting antibodies elicited by hapten HA-245 sharing a phenyl-contained linker exhibited obvious
linker recognition, and their binding abilities with HA were masked to a large extent when performing
ic-ELISA using homogenous coating haptens. However, the linker recognition was eliminated in
heterologous ic-ELISA where hapten (Hapten B) designed to have an aliphatic linker in the same
position as that in immunizing hapten (HA-245) was used as linker-heterologous coating hapten,
and significantly improved the binding abilities with HA were observed for these antibodies.
In summary, this investigation demonstrated the effectiveness of modulating the linker composition
of immunizing haptens from conventionally preferred linear aliphatic linker to a phenyl-contained linker
in improving the quality of antibodies against HA. However, for this hapten design strategy, it should
be noted: (i) The incorporation of phenyl-contained linker should not induce physico-chemical
and antigenic interference over the hapten as much as possible, which could be assessed by the
computer-assisted molecular modeling; (ii) when developing the immunoassay, it is necessary to
eliminate the linker recognition by using linker-heterologous haptens which have a phenyl-free linker
as competitive haptens. This work realized derivatization-free immunoassay for HA and provided a
valuable guidance for hapten design and development of immunoassays for other small molecules.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-273X/9/10/597/s1,
Figure S1: 1H NMR spectrum of hapten HA-245, Figure S2: ESI-MS spectrum of hapten HA-245, Figure S3: Effect
of different matrix dilution factors on recoveries of HA from the saury, red wine, soy sauce and yoghurt samples
spiked at 5 mg/kg or 5 mg/L (n = 3), Table S1: Effect of physicochemical parameters on ic-ELISA performance
(n = 3), Table S2: Comparison of the blind analysis results for HA by ic-ELISA and LC-MS/MS, Table S3: Synopsis
of conventional linear aliphatic linker contained haptens against histamine, acrylamide, ethyl carbamate and AOZ.
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